Demographics and Geographic Accessibility of Invasive Fungal Infection Clinical Trial Sites - Top-Institutions - MDSpire

Demographics and Geographic Accessibility of Invasive Fungal Infection Clinical Trial Sites

  • By

  • Lucy X. Li

  • Jiashu Xue

  • Olivia S. Kates

  • Robin K. Avery

  • Sean X. Zhang

  • John W. Baddley

  • Christine M. Durand

  • Nitipong Permpalung

  • June 11, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Disease

  • #2

    French National Reference Center for Invasive Mycoses and Antifungals (NRCMA)
    French National Reference Center for Invasive Mycoses and Antifungals (NRCMA)

    Paris, France

    Key Differentiators

    • Infectious Disease

  • #3

    European Society of Clinical Microbiology and Infectious Diseases
    European Society of Clinical Microbiology and Infectious Diseases

    Amsterdam, Netherlands

    Key Differentiators

    • Infectious Disease

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Infectious Disease

Original Source(s)

Demographics and Geographic Accessibility of Invasive Fungal Infection Clinical Trial Sites

  • by Lucy X. Li, Jiashu Xue, Olivia S. Kates, Robin K. Avery, Sean X. Zhang, John W. Baddley, Christine M. Durand, Nitipong Permpalung

  • June 11, 2026

Related Content

Case Report: Genetically primed hyperinflammation: cytomegalovirus-triggered HLH-like syndrome in an adolescent with a gain-of-function STING1 (p.Arg281Trp) variant with novel autosomal dominant inheritance and atypical presentation

Ebola outbreak response requires engaging with religious traditions and leaders

Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV